Clinical Trials
5 trialsNCT05235100 2025-12-11
SPARE-02
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Completed
NCT04690231 2022-03-15
Apatinib + Ifosfamide and Etoposide for Relapsed or Refractory Osteosarcoma
Peking University People's Hospital
Phase NA Completed
NCT04260113 2021-01-05
AIAC
Peking University People's Hospital
Phase NA Completed
NCT03359018 2020-05-19
APFAO
Peking University People's Hospital
Phase 2 Completed
NCT02711007 2018-04-23
Apatinib for Advanced Osteosarcoma After Failure of Standard Multimodal Therapy
Peking University People's Hospital
Phase 2/3 Completed